26 July 2022
Ropes & Gray Advises Ginkgo Bioworks in $300 Million All-Stock Acquisition of Zymergen
Advising firms
Deal team
26 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Suni Sreepada Lead | Ropes & Gray | Partner | mergers & acquisitions | Not stated |
| Kate Fisher Lead | Ropes & Gray | Associate | mergers & acquisitions | Not stated |
| Marko Zatylny Lead | Ropes & Gray | Partner | mergers & acquisitions | Not stated |
| Amanda Austin | Ropes & Gray | Partner | IP transactions | Not stated |
| Renata Ferrari | Ropes & Gray | Partner | employment & benefits | Not stated |
| Richard Kidd | Ropes & Gray | Partner | employment & benefits | Not stated |
| Megan Bisk | Ropes & Gray | Partner | employment & benefits | Not stated |
| Pam Glazier | Ropes & Gray | Partner | tax | Not stated |
| Lisa Bebchick | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Mike McFalls | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Martin Crisp | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Ama Adams | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Ruchit Patel | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Kellie Combs | Ropes & Gray | Partner | life sciences regulatory & compliance | Not stated |
| Peter Alpert | Ropes & Gray | Partner | real estate | Not stated |
| Ed McNicholas | Ropes & Gray | Partner | data, privacy & cybersecurity | Not stated |
| Melissa Rones | Ropes & Gray | Partner | IP transactions | Not stated |
| Andrew Devore | Ropes & Gray | Partner | business restructuring | Not stated |
| Milap Patel | Ropes & Gray | Partner | private equity | Not stated |
| Leslie Thornton | Ropes & Gray | Counsel | health care | Not stated |
| Beth Weinman | Ropes & Gray | Counsel | life sciences regulatory & compliance | Not stated |
| Deidre Johnson | Ropes & Gray | Counsel | litigation & enforcement | Not stated |
| Alison McLaughlin | Ropes & Gray | Counsel | litigation & enforcement | Not stated |
| Joseph Rafferty | Ropes & Gray | Counsel | litigation & enforcement | Not stated |
| Laurie Nelson | Ropes & Gray | Counsel | real estate | Not stated |
| James Kaplan | Ropes & Gray | Counsel | private equity | Not stated |
Stated terms
- Stated value
- USD 300m ($300 million)
- What the figure measures
- Total transaction value
- Client
- Ginkgo BioworksBuy-side
- Counterparties
- Zymergen (Sell-side)